Cited by 343Tissue Engineering and Regenerative Medicine3D Printing in Biomedical ResearchMechanical Circulatory Support Devices

Bioengineering human myocardium on native extracellular matrix

Open access
Guyette, Jacques P., Charest, Jonathan M., Mills, Robert W., Jank, Bernhard J., Moser, Philipp T., Gilpin, Sarah E., Gershlak, Joshua R., Okamoto, Tatsuya +4 more·2016·Circulation Research

Abstract

Rationale: More than 25 million individuals have heart failure worldwide, with ≈4000 patients currently awaiting heart transplantation in the United States. Donor organ shortage and allograft rejection remain major limitations with only ≈2500 hearts transplanted each year. As a theoretical alternative to allotransplantation, patient-derived bioartificial myocardium could provide functional support and ultimately impact the treatment of heart failure. Objective: The objective of this study is to translate previous work to human scale and clinically relevant cells for the bioengineering of functional myocardial tissue based on the combination of human cardiac matrix and human induced pluripotent stem cell–derived cardiomyocytes. Methods and Results: To provide a clinically relevant tissue scaffold, we translated perfusion-decellularization to human scale and obtained biocompatible human acellular cardiac scaffolds with preserved extracellular matrix composition, architecture, and perfusable coronary vasculature. We then repopulated this native human cardiac matrix with cardiomyocytes derived from nontransgenic human induced pluripotent stem cells and generated tissues of increasing 3-dimensional complexity. We maintained such cardiac tissue constructs in culture for 120 days to demonstrate definitive sarcomeric structure, cell and matrix deformation, contractile force, and electrical conduction. To show that functional myocardial tissue of human scale can be built on this platform, we then partially recellularized human whole-heart scaffolds with human induced pluripotent stem cell–derived cardiomyocytes. Under biomimetic culture, the seeded constructs developed force-generating human myocardial tissue and showed electrical conductivity, left ventricular pressure development, and metabolic function. Conclusions: Native cardiac extracellular matrix scaffolds maintain matrix components and structure to support the seeding and engraftment of human induced pluripotent stem cell–derived cardiomyocytes and enable the bioengineering of functional human myocardial-like tissue of multiple complexities.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circresaha.115.306874

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Engineered tissues with contractile forces and conduction properties approaching native myocardium have been reported by several groups.

    “A number of groups have reported engineered tissues with contractile forces and conduction properties approaching physiologic levels observed in native myocardium [8,13,31,32].”

    From Bioengineering an electro-mechanically functional miniature ventricular heart chamber from human pluripotent stem cells (2018) · cites this paper as [31]

    The Results (Recellularization of myocardial slices and fibers; page unavailable) report contractile force and a conduction velocity of 32 ± 56 cm/s in engineered tissue. But the reported slice force reached 33.8% of native murine embryonic heart tissue, slice strain was below normal adult myocardium, and the copy gives no native-myocardium benchmark for conduction velocity. It therefore supports the presence of mechanical and electrical function, but not the full claim that both properties approached physiologic levels. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 99 references couldn’t be matched to a known paper.

Research works printed but not linked: 5

  1. [30]Rodriguez MLMC Sniadecki NJ Assessment of induced pluripotent stem cell-derived cardiac myocyte contractility using micropost arrays ASME 2013 Summer Bioengineering Conference; SBC2013–14640 V01AT15A005 2013 1A
  2. [32]Chong JJ Yang X Don CW Minami E Liu YW Weyers JJ Mahoney WM Van Biber B Cook SM Palpant NJ Gantz JA Fugate JA Muskheli V Gough GM Vogel KW Astley CA Hotchkiss CE Baldessari A Pabon L Reinecke H Gill EA Nelson V Kiem HP Laflamme MA Murry CE Human embryonic-stem-cell-derived cardiac myocytes regenerate non-human primate hearts Nature 2014 510 273 277 24776797 PMC4154594
  3. [53]Friess W Collagen--biomaterial for drug delivery European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e. V 1998 45 113 136 9704909
  4. [67]Warren L Manos PD Ahfeldt T Loh Y-H Li H Lau F Ebina W Mandal PK Smith ZD Meissner A Daley GQ Brack AS Collins JJ Cowan C Schlaeger TM Rossi DJ Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mrna Cell stem cell 2010 7 618 630 20888316 PMC3656821
  5. [79]Lu T-Y Lin B Kim J Sullivan M Tobita K Salama G Yang L Repopulation of decellularized mouse heart with human induced pluripotent stem cell-derived cardiovascular progenitor cells Nat Commun 2013 4 23942048

Cited by

Sorted by citations

Authors
Guyette, J. P., Charest, J. M., Mills, R. W., Jank, B. J., Moser, P. T., Gilpin, S. E., Gershlak, J. R., Okamoto, T., Gonzalez, G., Milan, D. J., Gaudette, G. R., & Ott, H. C.
Affiliations
  • Worcester Polytechnic Institute (US)
  • From the Center for Regenerative Medicine (J.P.G., J.M.C., B.J.J., P.T.M., S.E.G., T.O., G.G., H.C.O.), Cardiovascular Research Center (R.W.M., D.J.M.), Division of Cardiology (D.J.M.), and Division of Thoracic Surgery, Department of Surgery (H.C.O.), Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA (J.P.G., B.J.J., P.T.M., S.E.G., G.G., H.C.O.); Department of Biomedical Engineering, Worcester Polytechnic Institute, Worcester, MA (J.R.G., G.R.G.); and Harvard Stem Cell...
Venue
Circulation Research
Published
2016-01-08
Volume
118
Issue
1
Pages
56-72
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W1821166167
Cited by
343
References
99
Citations by year
2026: 13 · 2025: 19 · 2024: 19 · 2023: 26 · 2022: 31 · 2021: 50 · 2020: 37 · 2019: 36 · 2018: 45 · 2017: 38 · 2016: 27 · 2015: 2
FWCI
37.59
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institutes of Health (1dp2od008749-01)
  • National Heart, Lung, and Blood Institute (R01HL115282, R21HL108663, R21 HL108663-2)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK057521, P30DK043351)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (P30AR066261)
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Engineering › Biomedical Engineering › Mechanical Circulatory Support Devices
Keywords
bioartificial heart, human myocardium, cardiac extracellular matrix, decellularization, perfusion decellularization, iPSC-derived cardiomyocytes, heart failure, heart transplantation, cardiac tissue engineering, recellularization, electrical conduction, contractile force, left ventricular pressure
MeSH terms
Adult, Aged, Cell Differentiation, Extracellular Matrix, Female, Humans, Male, Middle Aged, Myocardium, Pluripotent Stem Cells, Bioengineering

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review